MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Industry news

Related news

Latest News

MediciNova Reports Third Quarter 2009 Results
Novartis launches Prevacid
Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries
MDRNA, Inc. Announces Third Quarter 2009 Financial Results
Nile Therapeutics Reports 2009 Third Quarter Financial Results
LAB RESEARCH ANNOUNCES ITS 2009 THIRD QUARTER FINANCIAL RESULTS
NOVELOS THERAPEUTICS CLOSES LAST TRANCHE IN $9 MILLION PRIVATE PLACEMENT
Neurologix Announces Third Quarter 2009 Financial Results
Champions Biotechnology to Present Data at AACR-EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft(TM) Platform to Guide Personalized Cancer Treatment and Accelerate Oncology Drug Development
Tobira Therapeutics Inc. Announce Presentation of TBR-652 Data at European AIDS Conference
More news... | RSS Feed...

Most Viewed

SRI International and F. Hoffmann-La Roche Launch Translational Medicine Collaboration to Study Methods and Treatments Associated with Cognitive Deficits across Neuropsychiatric Disorders

Cerimon Pharmaceuticals Acquires European Rights to Topical Diclofenac Patch Cerimon Also Completes Enrollment of Phase 3 Diclofenac Patch Studies in Acute Pain Company Also Receives Notice of...

Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline

Exelixis and Bristol-Myers Squibb Report New Phase 2 Data for XL184 in Patients With the Most Common and Aggressive Form of Brain Cancer

ELEKTA'S RADIOSURGERY SOLUTIONS ON CENTER STAGE AT 2009 CONGRESS OF NEUROLOGICAL SURGEONS ANNUAL MEETING EXTEND RECEIVES FDA 510(K) CLEARANCE

Therapeutic Target

Cardiovascular
Dermatology
Endocrine and Metabolic
Gastroenterology
Genitourinary
Hematology
Immunology and Allergy
Infection
Musculoskeletal
Neurology
Obstetrics and Gynecology
Oncology
Ophthalmology
Psychiatry
Pulmonary

Categories

Deals and Alliances
Development
Financial Results
Financings
Intellectual Property
Regulatory
Press releases
Deals review
Headlines
PR Newswire

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us